激素补充治疗对围绝经期女性肠道微生态的影响及其与骨代谢的相关性OA
The Effect of Hormone Replacement Therapy on Gut Microbiota in Perimeno-pausal Women and Its Correlation with Bone Metabolism
目的:探讨激素补充治疗(HRT)对围绝经期女性肠道菌群结构、多样性及粪便代谢物的影响,并分析其与骨代谢指标的相关性.方法:选取2021 年4 月至2022 年5 月就诊的48 例围绝经期患者,根据是否行 HRT 及治疗期限分为对照组(不使用 HRT,n=24)、短期补充组(治疗10~12 月,n=12)和长期补充组(治疗20~26 月,n=12).收集患者粪便样本,采用 16S rDNA 测序分析肠道菌群组成及多样性(Ace、Chao、Sobs、Shannon 指数),利用液相色谱-质谱联用技术进行非靶向代谢组学检测.同时,检测患者治疗前后腰椎 L1~4 及双侧股骨颈骨密度(BMD)、骨形成标志物Ⅰ型前胶原氨基末端肽(PINP)及骨吸收标志物Ⅰ型胶原羧基末端肽(CTX)水平.计算 Pearson 相关系数分析差异性代谢物与肠道菌群的相关性,采用 Spearman 相关性分析探讨差异性代谢物与骨代谢指标的关系.结果:①骨代谢指标比较显示,治疗后长期补充组的腰椎 L1~4 BMD、双侧股骨颈 BMD 及PINP 水平均显著高于短期补充组和对照组(P<0.05),而 CTX 水平则显著降低(P<0.05).②沿"门纲目科属种"依次寻找3 组间有差异的菌群发现:3 组厚壁菌门平均相对丰度、拟杆菌门平均相对丰度及厚壁/拟杆菌门丰度比值比较差异无统计学意义(P>0.05);3 组毛螺菌科、丁酸球菌科、克里斯滕森菌科平均相对丰度比较差异有统计学意义(P<0.05);普拉梭菌平均相对丰度长期补充组高于短期补充组,但差异无统计学意义(P>0.05).与对照组和短期补充组相比,长期补充组的肠道菌群 α 多样性指数(Ace、Chao、Sobs、Shannon 指数)均显著升高(P<0.05).③代谢组学分析显示,长期补充组中吲哚乙酸、花生四烯酸及 L-脯氨酸水平均显著高于其他两组(P<0.05).④相关性分析显示,吲哚乙酸、花生四烯酸、L-脯氨酸均与普拉梭菌呈正相关(r>0,P<0.05);将短期补充组及长期补充组合并为处理组(不区别 HRT 时间长短)后,发现吲哚乙酸含量与 PINP、腰椎 L1~4 BMD、双侧股骨颈 BMD 均呈正相关(r>0,P<0.05).结论:长期 HRT 可显著增加围绝经期女性肠道菌群的多样性,改变特定菌科(如毛螺菌科、克里斯滕森菌科、丁酸球菌科)的相对丰度,并上调粪便代谢物吲哚乙酸、花生四烯酸和 L-脯氨酸的水平.其中,吲哚乙酸与骨形成指标及 BMD 呈正相关,提示 HRT 可能通过调节肠道微生态及其代谢产物(尤其是吲哚乙酸)来改善围绝经期女性的骨代谢状态.调节肠道菌群组成或代谢物途径可能成为围绝经期管理的潜在策略.
Objective:To investigate the effects of hormone replacement therapy(HRT)on the structure,di-versity,and fecal metabolites of gut microbiota in perimenopausal women,and to analyze their correlations with bone metabolism indicators.Methods:A total of 48 perimenopausal patients who visited the hospital from April 2021 to May 2022 were enrolled.According to whether they received HRT and the treatment duration,they were di-vided into three groups:the control group(without HRT,n=24),the short-term supplementation group(treatment duration:10~12 months,n=12),and the long-term supplementation group(treatment duration:20~26 months,n=12).Fecal samples were collected from patients,and 16S rDNA sequencing was performed to analyze the composition and diversity of gut microbiota(including Ace,Chao,Sobs,and Shannon indices).Meanwhile,untar-geted metabolomics detection was conducted using liquid chromatography-mass spectrometry(LC-MS).Mean-while,bone mineral density(BMD)of the lumbar spine(L1~L4)and bilateral femoral necks,as well as the levels of procollagen type I N-terminal peptide(PINP,a bone formation marker)and C-terminal telopeptide of type I col-lagen(CTX,a bone resorption marker),were measured in patients before and after treatment.Pearson correlation coefficients were calculated to analyze the correlation between differential metabolites and gut microbiota,while Spearman correlation analysis was performed to explore the relationship between differential metabolites and bone metabolism indicators.Results:①Comparisons of bone metabolism indicators showed that after treatment,the BMD of the lumbar spine(L1~L4)(0.91±0.19 g/cm2),BMD of the bilateral femoral necks(0.94±0.14 g/cm2),and PINP levels(38.52±6.72 ng/ml)in the long-term supplementation group were significantly higher than those in the short-term supplementation group and the control group(P<0.05),while the CTX levels(535.19±21.59 pg/mL)were significantly lower.②Sequentially analyzing the differential microbiota among the three groups at the phylum,class,order,family,genus,and species levels revealed the following:there were no statistically significant differences in the average relative abundances of Firmicutes,Bacteroidetes,or the Firmi-cutes/Bacteroidetes ratio among the three groups(P>0.05);the average relative abundances of Lachnospirace-ae,Butyricicoccaceae,and Christensenellaceae were significantly different among the three groups(P<0.05);the average relative abundance of Faecalibacterium prausnitzii in the long-term supplementation group was higher than that in the short-term supplementation group,but the difference was not statistically significant(P>0.05).Compared with the control group and the short-term supplementation group,the gut microbiota α-diversity indices(Ace,Chao,Sobs,and Shannon indices)in the long-term supplementation group were significantly increased(P<0.05).③ Metabolomic analysis showed that the levels of indole-3-acetic acid,arachidonic acid,and L-proline in the long-term supplementation group were significantly higher than those in the other two groups(P<0.05).④Correlation analysis showed that indole-3-acetic acid,arachidonic acid(AA),and L-proline were all positively cor-related with Faecalibacterium prausnitzii(r>0,P<0.05);after merging the short-term supplementation group and the long-term supplementation group into a treatment group(regardless of the duration of HRT),it was found that the content of indole-3-acetic acid was positively correlated with procollagen type I N-terminal peptide(PINP),lumbar spine(L1~L4)BMD,and bilateral femoral neck BMD(r>0,P<0.05).Conclusions:Long-term HRT can significantly increase the gut microbiota diversity of perimenopausal women,alter the relative abundances of spe-cific bacterial families(e.g.,Lachnospiraceae,Christensenellaceae,and Butyricicoccaceae),and upregulate the fecal metabolite levels of indole-3-acetic acid,arachidonic acid,and L-proline.Among these metabolites,in-dole-3-acetic acid is positively correlated with bone formation markers and BMD,suggesting that HRT may im-prove bone metabolism in perimenopausal women by regulating the gut microecology and its metabolites(espe-cially indole-3-acetic acid).Modulating the gut microbiota composition or metabolite pathways may serve as a po-tential strategy for perimenopausal management.
沈苗;俞丹青;程建霞;孔建平;金敏
建德市第一人民医院妇产科,浙江 杭州 311600浙江大学医学院附属第二医院生殖医学科,浙江 杭州 310009建德市第一人民医院妇产科,浙江 杭州 311600建德市第一人民医院妇产科,浙江 杭州 311600浙江大学医学院附属第二医院生殖医学科,浙江 杭州 310009
医药卫生
围绝经期激素补充治疗肠道菌群骨代谢粪便代谢物吲哚乙酸
PerimenopauseHormone replacement therapyGut microbiotaBone metabolismFecal metabo-litesIndole-3-aceticacid
《实用妇产科杂志》 2026 (3)
256-262,7
杭州市医药卫生科技项目(编号:ZD20250288)
评论